Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 02 Jun 2026
Novartis said on Sunday that early data from its experimental actinium-based drug showed signs of anti-tumour activity against prostate cancer, including in patients...
Read Full NewsBritish lawmakers rejected on Friday a proposal to legalise assisted dying for terminally ill people, dealing a major setback to campaigners and bringing the latest effort...
In a global review, legalization was associated with increased cannabis use and related emergency department visits, with potential decreases in the use of alcohol and tobacco.
Researchers analyzed plasma samples collected from 313 patients with early breast cancer approximately 2 years after they had completed adjuvant chemotherapy.
Patients who respond to neoadjuvant immunochemotherapy may be able to undergo less extensive surgery, with high rates of disease control and organ preservation.
In patients with first- or second-line Philadelphia-positive B-cell acute lymphoblastic leukemia, favorable outcomes are observed with discontinuation of ponatinib.
For patients with early-stage, inoperable lung cancer, adding atezolizumab to standard radiotherapy boosts toxicity, not survival.
1.
The Predictive Power of Liquid Biopsy in Colon Cancer Outcomes Is Inconsistent.
2.
'Next Berlin Patient' Adds to Small but Growing Number of People Cured of HIV
3.
Patellar Resurfacing in Total Knee Replacement; Patient Messaging Trends
4.
GuCS Future Focus: Future Focus from the Genitourinary Cancers Symposium
5.
Less Seniors Taking Inappropriate Cognitive Meds
1.
Drug Safety Through Oncology Survivorship Medication Monitoring Frameworks
2.
Anion Gap: The Simple Calculation That Reveals Much About Your Health
3.
Breakthroughs in Cancer Care: From Rare Diagnoses to Advanced and Early-Stage Treatments
4.
Iron Deficiency Anemia: Modern Diagnostic Approaches and Personalized Treatment Strategies
5.
Metabolic Tumor Risk Profiling Through Preventive Oncology Screening
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Virtual Case Study on Pedal Edema and Triple Vessel Disease - An Initiative by Hidoc Dr.
2.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VII
3.
Optimizing Treatment Options in Advanced Urothelial Carcinoma
4.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases
5.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VI
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge